It was a pleasure to receive Frank Stangenberg-Haverkamp, Chairman of the Executive Board of Merck KG and Bruno Wohlschlegel, Managing Director of Merck Portugal at iBET last November 3rd.
iBET has been proudly collaborating with Merck since 1997. 
Recently Merck has established a partnership with iBET to develop a project to fight Malaria in Africa; a project that has the objective to establish a cellular screening platform for the discovery of new anti-malarial drugs which act on the liver stage of infection.